Objective: The aim of this study was to compare differences in expressions and relationships between key genes involved in extracellular matrix metabolism and tissue cellularity in women with and without pelvic organ prolapse (POP).
Results: Bone morphogenetic protein 1 expression was significantly upregulated in patients with POP compared with controls. Bone morphogenetic protein 1 expression was correlated with COL1 expression in all groups but only correlated with TIMP metallopeptidase inhibitor 3 expression in controls. Similarly, COL3 expression was correlated with RXFP1 expression in women with POP but not in controls. The degree of dependence (slope of the regression line) between COL1 and COL3 expressions was significantly elevated in premenopausal women with POP compared with the other 2 groups. The slopes between COL1-COL3, COL3-matrix metallopeptidase 2, COL1-RXFP1, and COL3-RXFP1 expressions were significantly lower in postmenopausal women compared with premenopausal women with POP. No differences were found in overall tissue cellularity.
Conclusions: Bone morphogenetic protein 1 expression may play a significant role in the pathophysiology of POP. The finding that BMP1 expression was correlated with COL1 expression in all groups suggests a conserved association between BMP1 and collagen synthesis in the vaginal wall. The elevated slope between COL1 and COL3 expressions may be associated with early (premenopausal) development of POP. The expression of RXFP1 in postmenopausal women and its altered intergene regulation suggests a role for RXFP1 in connective tissue metabolism outside pregnancy.
Key Words: pelvic organ prolapse, bone morphogenetic protein 1, relaxin family peptide receptor 1, collagen metabolism, tissue cellularity (Female Pelvic Med Reconstr Surg 2017;23: [44] [45] [46] [47] [48] [49] [50] [51] [52] P elvic organ prolapse (POP) is defined as the descent of the anterior, posterior, and/or apical vaginal compartment(s) with protrusion of one or more of the pelvic organs. 1 These pathological changes, which result from loss of structural support to the pelvic organs, can greatly reduce a woman's quality of life. 2, 3 More than 12% of all women will require surgery for POP by the age of 80 years, and this demand is expected to rise significantly by 2030. 4, 5 Despite the high incidence of POP, little is known regarding its pathophysiology. Therefore, current treatment options primarily involve surgical reconstruction, which does not address the underlying mechanisms of the disease. 6, 7 The pelvic organs are held in a proper anatomical position via a complex system of supportive structures that includes both the skeletal muscles and connective tissues. Childbirth trauma, for example, to the levator ani, is associated with POP; however, a significant proportion of women develop POP with no identifiable anatomical injuries. 8 Furthermore, cesarean section does not completely eliminate the risk of POP. [9] [10] [11] Therefore, childbirth trauma does not provide a complete explanation for the pathophysiology of POP, and genetics likely plays an important role, suggesting that aberrant connective tissue metabolism may be important for the development of POP. 12, 13 This is further highlighted by the higher rates of POP in women with underlying connective tissue disorders such as Marfan and Ehlers-Danlos syndromes. 14 The pelvic organs are primarily supported by collagen and elastic fibers within the pelvic connective tissues. These fibers are maintained by equilibrium between synthesis and degradation. 3, [15] [16] [17] During pregnancy and parturition, both collagen and elastic fibers undergo significant remodeling to accommodate gestation and in preparation for childbirth. [18] [19] [20] This tissue remodeling is triggered by pregnancy hormones, particularly relaxin, which has been shown to induce dramatic collagen and elastic fiber remodeling. 21, 22 Throughout the reproductive cycle and in steady state, connective tissue metabolism is regulated by a variety of genes including matrix metallopeptidases (MMPs), their tissue inhibitors (TIMPs), and genes involved in collagen and elastin synthesis. 15 All MMPs can degrade 1 or more components of the extracellular matrix (ECM), and their expression can be induced by various growth factors and cytokines and by cell-to-ECM interactions. 23, 24 To date, 4 TIMPs have been identified, and, with the exception of TIMP1, which does not bind MMP14, TIMPs have been shown to inhibit all other MMPs. 25 Collagens in the pelvic connective tissues are composed primarily of collagen III (82%) and collagen I (13%). 17 The major components of these proteins are encoded by the collagen types I and III α-1 genes. Unlike collagens, elastic fibers are normally a stable component of the ECM and turn over primarily during pregnancy and parturition. 26 The synthesis of elastic fibers requires tropoelastin (the monomeric form of elastin) and several cross-linking enzymes including lysyl oxidases and fibulins. 27 From the *Department of Biomedical Engineering, Cleveland Clinic; †Depart-ment of Chemical & Biomedical Engineering, Cleveland State University; ‡De-partment of Obstetrics & Gynecology and §Glickman Urological and Kidney Institute, Cleveland Clinic; and ||Advanced Platform Technology Center, LouisLysyl oxidases, which cross-link both collagens and elastin, require activation by bone morphogenetic protein 1 (BMP1), a matrix metalloproteinase that also cleaves the C-terminal propeptide of procollagen chains. 28 Cellular proliferation of pelvic connective tissue fibroblasts also seems to be involved in the pathophysiology of POP. 29, 30 Cardinal ligament fibroblasts obtained from women with POP have a significantly slower growth rate compared with those obtained from women without POP. Moreover, 17β estradiol suppresses the proliferation of fibroblasts, but the inhibitory effect seems to be more prominent in fibroblasts from women with POP. 29 In contrast, in vivo studies have suggested an increase in the proliferation of fibroblasts and decreased levels of p53 and p21 (proteins known to arrest cell cycle at G1) in women with POP compared with women without POP. 30 In this study, we hypothesized that (1) the expression of and relationships between genes involved in connective tissue metabolism are altered in women with POP compared with women without POP and (2) connective tissue cellularity is increased in the vaginal subepithelia of women with POP compared with women without POP. To this end, we aimed to investigate the gene expression of BMP1, collagen types I and III α-1, relaxin family peptide receptor 1 (RXFP1), MMP2, TIMP2, and TIMP3, as well as tissue cellularity in premenopausal and postmenopausal women. Given the complex interactions between these genes, we also aimed to identify genes whose expressions are correlated and determine differences in these correlative relationships between groups, yielding mechanistic insight into the pathophysiology of POP.
MATERIALS AND METHODS
This study was approved by the institutional review board of the Cleveland Clinic and was a planned secondary analysis of specimens obtained from a previously described group of women with and without POP. 31 Women with symptomatic stage II or greater POP who elected to undergo surgical repair were included in the POP group. This group was further divided into 2 subgroups based on age and menopause status: premenopausal women younger than 40 years (premenopausal POP group) and postmenopausal women older than 40 years who were not taking oral or vaginal estrogen replacement therapy (postmenopausal POP group). Menopause was defined as greater than 1 year of cessation of menstruation, and there was no overlap with regard to menopause status between premenopausal and postmenopausal groups.
As previous authors using similar study designs have noted, the most common benign indication for hysterectomy in postmenopausal women is POP, which makes obtaining "healthy" tissues from postmenopausal women relatively difficult. 32 Furthermore, it has been suggested that premenopausal tissues may represent an ideal reference for normal pelvic support. 32 Therefore, we identified patients for our control group by searching through the operating room schedule for patients younger than 40 years who were undergoing hysterectomy for benign reasons. Each potential subject underwent a focused history and physical examination including detailed pelvic examination by a gynecologist. To be included in the study, the patient had to deny bulge symptoms, and the examination had to confirm that no vaginal compartment was within a centimeter of the hymen while straining (POP quantification [POP-Q] stage 0 or I). Women with clinical or occult incontinence were allowed in the study. Women who had a history of previous prolapse surgery or malignant disease or who were younger than 18 years were excluded. Age and body mass index (BMI) data were collected through a review of the medical records, and data pertaining to obstetric history (ie, maximum newborn weight, mode of delivery, >2-degree obstetric laceration) were collected by patient recall.
After informed consent, a total of 80 biopsies were obtained from 30 women (n = 10, each group) who met the inclusion criteria. Women with POP underwent vaginal biopsies from 3 sites (leading edge, anterior, and posterior cuffs) at the time of prolapse repair (n = 60 biopsies in total). Subjects without POP underwent biopsies at the anterior and posterior cuffs at the time of hysterectomy (n = 20 biopsies in total). Surgeons were instructed to obtain full-thickness vaginal wall biopsies of approximately 1 cm 2 . Each specimen was embedded in optimal cutting temperature media, snap frozen with liquid nitrogen, and stored at −80°C.
RNA Isolation and Complementary DNA Generation
Ten-micron-thick shavings from frozen tissue blocks were obtained, and total RNA was isolated using the RNAqueous-4PCR kit (Cat. AM1914; Life Technologies, Grand Island, NY) according to the manufacturer's protocol. After DNase treatment and inactivation, the RNA concentration of each sample was determined using a NanoDrop ND-1000 Spectrophotometer (ThermoScientific, Wilmington, Del). The mean 260/280 ratio was 2.02 ± 0.09, which is considered acceptable for RNA analysis. Reverse transcription was performed using the highcapacity complementary DNA reverse transcription kit with RNase inhibitor (Cat. 4374966; Life Technologies, NY) in a 20-μL reaction volume with 250 ng of total RNA, random primers, dNTP mix, 20 units of RNase inhibitor, and 1 unit of MultiScribe reverse transcriptase at 25°C for 10 minutes, 37°C
for 120 minutes, and 85°C for 5 minutes.
Quantitative Reverse-Transcriptase Polymerase Chain Reaction
Quantitative reverse-transcriptase polymerase chain reaction (PCR) was used to assess gene expression. Approximately 30 ng of input complementary DNA was used in each 25-μL amplification reaction using TaqMan Gene Expression Master Mix (Cat. 4369016; Life Technologies, Grand Island, NY) and TaqMan primer-probes (Table 1) . Each reaction was carried out using the ABI 7500 real-time PCR system (Life Technologies, Grand Island, NY). The standard curve method was used to determine the relative amount of each target gene.
Histological Analysis
Hematoxylin and eosin staining was used to ensure biopsies were in full thickness (including lamina propria and muscularis) , and the mean values of the 3 fields were used for analyses.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism Version 6.05 (GraphPad Software Inc, La Jolla, Calif ). The Kruskal-Wallis test followed by Dunn post hoc test or the Mann-Whitney U test were used, as appropriate, to compare the different study groups and biopsy sites. Pearson correlation analysis was performed between genes within each group to identify genes that are co-expressed (ie, linearly associated). To determine whether the degree of dependence between a gene-gene pair in 1 group was significantly different from that of another group, linear regression analysis was performed separately between the groups, and a 2-sample t test followed by Bonferroni correction for multiple comparisons was used to test the slopes of the regression lines for significant differences. Correlations between cellularity of the stromal layer and genes were assessed similarly. Categorical values in demographics were compared using the χ 2 test or Fisher exact test, as appropriate. The robust regression and outlier removal method was used to identify potential outliers for relative gene expression comparisons and linear regression analysis. 33 In all cases, P < 0.05 was used to determine statistically significant differences between groups. Data are presented as mean ± SE, slope ± SE, or median with interquartile range.
RESULTS
Thirty subjects were included in this study. Postmenopausal women were significantly older than women in both the premenopausal POP and control groups (P < 0.001), and women in the premenopausal POP group had significantly lower BMI than those in the control group (P = 0.048). There were no significant differences between groups with regard to maximum newborn weight, mode of delivery, or history of obstetrical tears ( Table 2) .
Comparison of relative gene expression levels between groups was used to determine genes that are up-regulated or down-regulated among the 3 groups (Fig. 1) . To prevent bias due to biopsy sites, comparisons against controls were performed using data from only the anterior and posterior cuff biopsies obtained from premenopausal and postmenopausal POP groups. Overall, BMP1 was significantly up-regulated in both postmenopausal (2.46 ± 0.33 vs 1.11 ± 0.16, P = 0.012) and premenopausal (2.33 ± 0.35 vs 1.11 ± 0.16, P = 0.025) women with POP compared with controls. Furthermore, a pairwise analysis between individual biopsy sites showed significantly up-regulated BMP1 in the anterior cuffs of premenopausal (2.23 ± 0.56 vs 1.01 ± 0.07, P = 0.032) and postmenopausal (2.36 ± 0.29 vs 1.01 ± 0.07, P = 0.002) women with POP compared with controls. No other significant differences in relative gene expression levels were found between the 2 POP groups compared with controls.
The pairwise analysis of individual biopsy sites between groups revealed that specimens obtained from the leading edge in patients in the premenopausal POP group had a significantly higher expression of MMP2 compared with leading edge specimens from the postmenopausal POP group (1.18 ± 0.22 vs 0.61 ± 0.13, P = 0.0435). No significant differences were found between posterior and anterior cuff biopsies in any group. Interestingly, COL1, TIMP2, and TIMP3 were all significantly down- and TIMP3 expressions were correlated only in the control group (CC, 0.564; P = 0.036). In addition, COL1 expression was correlated with TIMP3 expression in the POP groups (CC: premenopausal, 0.684, P < 0.001; postmenopausal, 0.466, P = 0.012), but not in the control group (CC, 0.308; P = 0.245). Similarly, TIMP2 and TIMP3 expressions were correlated in the POP groups (CC: premenopausal, 0.640, P < 0.001; postmenopausal, 0.553, P = 0.002), but not in the control group (CC, 0.462; When correlations between any gene-gene pair were significant in more than 1 study group, linear regression analyses followed by a 2-sample t test for a comparison between the 2 groups were performed. The magnitude of correlation (ie, slope of the regression line) between COL3 and MMP2 was significantly smaller in postmenopausal women with POP compared with both the premenopausal POP group and controls (P = 0.012 and P = 0.003, respectively). Similarly, the slopes of regression lines between COL1-COL3, COL1-MMP2, COL1-RXFP1, COL3-MMP2, COL3-RXFP1, and MMP2-RXFP1 were significantly decreased in postmenopausal women compared with premenopausal women (Fig. 2, Table 3 ).
With regard to cellularity of the vaginal subepithelium, we found no significant difference between groups or biopsy sites 
DISCUSSION
Most studies investigating the role of connective tissue metabolism in the pathophysiology of POP have focused on alterations at the protein level. However, we chose to focus our investigation at the transcriptional level because many connective tissue metabolism genes, especially MMPs and TIMPs, are primarily regulated at this level. Previously published work on this subject has demonstrated conflicting findings, perhaps because of differences in biopsy sites 34 (Table 4) . However, our study is the first to assess the correlational relationships between these genes, which we believe are helpful in elucidating the pathophysiological pathways involved. 46, 47 Of the previously published studies that investigated gene expression levels in women with POP compared with controls, only one assessed BMP1. 37 In their study, the authors found a 3-fold reduction in BMP1 gene expression in women with POP compared with controls. It is important to note that the reported messenger RNA (mRNA) sequence used in that study (GenBank, NM_006132) has been permanently removed from the GenBank database as it has been found to be a target of nonsense-mediated mRNA decay and thus not translated into protein.
48-50 Nonsensemediated mRNA decay pathways exist in all eukaryotic cells and serve to degrade mRNA transcripts that contain premature stop codons, which, if translated, could lead to an accumulation of harmful truncated proteins. [39] [40] [41] Therefore, because the reported mRNA sequence used in that study has been identified as a target for nonsense-mediated mRNA decay, the targeted transcripts may have been subjected to degradation, which adds significant uncertainty to the interpretation of relative gene expression. 51, 52 Furthermore, the analysis of BMP1 protein levels was conflicting in this previous article. 37 The authors found downregulated protein levels of the 130-, 92.5-, and 82.5-kDA isoforms of BMP1 and no differences in the 70-kDa isoform in postmenopausal women with POP (n = 7) compared with controls (n = 4). However, they found up-regulated protein levels of the 130-kDA isoform and no differences in the 92.5-, 82.5-, and 70-kDa isoforms in premenopausal women with POP (n = 14) compared with controls (n = 7).
In our study, we found that BMP1 gene expression was more than 2-fold higher in women with POP (n = 20) compared with controls (n = 10), regardless of menopause status. In addition, we found that BMP1 was positively correlated with COL1 in all study groups (Fig. 2) , although COL1 expression was not significantly different between the groups. This suggests that the increase in BMP1 expression in women with POP indicates a state The finding that BMP1 was correlated to connective tissue cellularity in the premenopausal POP group implicates a role for apoptotic pathways in the development of POP in this group of patients. We also found that RXFP1, which other studies have found to be involved in prostate cancer growth, 53 was positively correlated with tissue cellularity. Indeed, several studies have found alterations in apoptosis-related mechanisms in women with POP compared with controls. [54] [55] [56] Wen et al 54 found that women with POP have an increased cellular sensitivity to apoptosis in the vaginal tissues, as determined by ratios between proapoptotic and antiapoptotic gene expression levels. Similarly, Bai et al 56 found a decreased protein expression of the tumor suppressor genes p53 and p21 in patients with POP compared with controls. With regard to tissue cellularity, Takacs et al 55 conducted a histological study comparing women with (n = 6) and without (n = 6) POP. In their study, the authors counted only smooth muscle cells identified by α-actin staining and found that women with POP have a decreased number of smooth muscle cells compared with controls (1166 ± 727 vs 2370 ± 467, P < 0.01). 55 In contrast, we found no differences in total connective tissue cellularity in women with POP compared with those without (2013 ± 505 vs 2058 ± 444, P = 0.87). Collectively, this indicates that, although total tissue cellularity may be the same, the proportion of cell staining for smooth muscle α-actin may be decreased in women with POP compared with controls.
Despite using the standard curve method for quantitative reverse-transcriptase PCR analysis, which is more sensitive to small changes in gene expression levels than the comparative CT method, we found no differences in the expression levels of MMP2, TIMP2, and TIMP3. Similarly, Chen et al 35 used an absolute quantification method and found no differences in the expression levels of these genes. With regard to TIMP2 and TIMP3, our study is the third study to find no differences in the vaginal wall of patients with POP compared with controls. 35, 38 Despite their different methodologies, the unanimity between these studies suggests more conclusively that the overall expression levels of TIMP2 and TIMP3 are not altered in the vaginal wall of women with POP. However, a role for these genes in the pathophysiology of POP cannot be ruled out. We found that COL1 and TIMP2 were correlated with TIMP3 in both premenopausal and postmenopausal women with POP but not in the control group, suggesting alterations in the regulation of connective tissue modeling in patients with POP (Fig. 2) .
Our findings with regard to COL1 and COL3 contradict those of Mosier et al, 36 who found increased levels of both genes in postmenopausal women with POP compared with agecomparable controls. This discrepancy could be due to differences in the control groups. In their study, the control group consisted of women undergoing radical cystectomy for invasive bladder cancer, whereas our control group consisted of women undergoing hysterectomy for benign indications. Although we found no differences in the overall expression levels of COL1 and COL3, we found a significantly larger slope (ie, closer correlation in expression) between COL1 and COL3 expressions in premenopausal women with POP compared with both controls and postmenopausal women with POP ( Table 3 ), suggesting that the abnormal regulation of COL1 and COL3 may contribute to the early predisposition to POP in premenopausal women.
We also found significant differences in the relationships between these genes and RXFP1 because the slope of the regression line between RXFP1 and both COL1 and COL3 in postmenopausal women with POP was significantly less than that in premenopausal women with POP. Furthermore, the slopes between COL3-MMP2 and MMP2-RXFP1 were both significantly lower in postmenopausal women compared with premenopausal women with POP. Relaxin (a ligand for RXFP1) is predominantly produced by the corpus luteum and placenta during pregnancy; however, it is also produced by the breast and prostate and is detectable in serum outside pregnancy. 57 Although we found no differences in overall RXFP1 expression levels, which corroborate results from previous reports comparing uterosacral ligament biopsies, 44 our findings of altered intergene regulation and the fact that it is expressed in postmenopausal women with POP suggest a role for RXFP1 in connective tissue metabolism outside pregnancy.
A limitation of our study is that women in the control group did not undergo the same standardized POP-Q examination as women in the POP groups. Therefore, this group likely included some women with stage I POP, which could be indicative of a pathophysiological process in progress. Moreover, most patients in the POP groups had stage II or III prolapse, with only 1 patient with stage IV prolapse. This may have dampened our results given that, if we had included more patients with stage III and IV prolapse, we may have seen greater differences. Nonetheless, we still found significant differences between controls and both premenopausal and postmenopausal women with POP.
Another limitation of this study is that protein expression levels were not assessed. However, our aim was to assess the regulation of connective tissue metabolism downstream of translation to identify differences in gene expression, as well as genes that are co-expressed. Gene expression correlational analyses are routinely performed throughout the basic sciences, and co-expressed genes are of biological interest because they are likely controlled by the same transcriptionally regulatory pathway and are functionally related. 46, 47, 58 Given our results regarding increased BMP1 mRNA levels in women with POP compared with those without POP, comprehensive analyses of the various isoforms of this protein should be an area of future research.
In future work, protein expression could be correlated with severity of symptoms. Because the aim of the current study was to assess the expression and correlation of multiple genes, it was not powered to also correlate expression to the severity of symptoms. Nonetheless, the results of our study could provide rationale for future studies because a strength of our study is the use of robust correlational analyses in addition to the assessment of gene expression levels. Using this method, we were able to more comprehensively characterize the transcriptional regulation of various connective tissue metabolism genes that may be associated with POP. Overall, our results help elucidate potential molecular pathways involved in the pathophysiology of POP.
